|
South Korea Pharmaceuticals News. Service for global professionals. Constantly updated news and information about South Korea.
Latest South Korea Pharmaceuticals News
- Echo Therapeutics CEO Interviewed by Stockgoodies.com 5 Jan 2010 13:30 GMT
... Therapeutics, Inc. (OTC Bulletin Board: ECTE), a company developing its needle-free Symphony(TM) tCGM System as ... Kingdom, and a license agreement with Handok Pharmaceuticals Co., Ltd. granting Handok a license to ... System for needle-free continuous glucose monitoring in South Korea. In addition, he discussed the positive ...
- Korea Inc. in Dispute Over Inheritance 5 Jan 2010 12:23 GMT
... By Park Si-soo Staff Reporter An upward trend in family ... around one trillion won ($870 million). The Seoul Central District Court said Tuesday that two ... Huh Sung-soo, 39, vice president of domestic pharmaceutical company Green Cross, filed a suit against ...
- Formatech's "Fillanthropy Program" Donates Services to Formulate and Fill ViroMed's VM206 Vaccine Targeting Breast Canc 5 Jan 2010 10:49 GMT
... ANDOVER, Mass. - (BUSINESS WIRE) - Today, Formatech has ... of science." ViroMed Co., Ltd. is a biopharmaceutical development company located in Seoul, Korea, focusing on novel DNA and protein-based ...
- RGA Technology Partners, Inc. Brings Automated Underwriting to AAA Life Insurance Company 5 Jan 2010 08:51 GMT
... able to gain efficiencies in their new business and underwriting operations from the ability to ... able to take advantage of AURA's expanded pharmaceutical (Rx) rule set capabilities recently developed by ... Kong, India, Ireland, Japan, Mexico, South Africa, South Korea, Spain, Taiwan, and the United Kingdom. ...
- Tuesday Newspaper Review - Irish Business News and International Stories - - January 05, 2010 5 Jan 2010 07:11 GMT
... Similar data amplified evidence of recovery in South Korea, India and Taiwan. “Strong growth in ... ITG, but rather the return to everyday business after an overreaction to the terror that ... financial services companies, natural resource groups and pharmaceutical giants. Few companies will discuss the subject. ...
- Japanese Market Trades Firm On Wall Street Cues, Higher Metal Prices 5 Jan 2010 02:31 GMT
... that the company's Taiwanese subsidiary Rexchip Electronics Corp. will more than double chip output in fiscal 2010. Pharmaceutical stock Dainippon Sumitomo extended recent gains following ... and Taiwan are trading notably higher, while South Korea is up with a modest gain. ...
- Tax Enforcers Intensify Focus on Multinationals 5 Jan 2010 02:10 GMT
... how much profit is made by a company in each country in which it operates, ... KPMG study found that China, India, Australia, South Korea and Japan in particular have intensified ... financial services companies, natural resource groups and pharmaceutical giants. Few companies will discuss the subject. ...
- China and India leading strong Asian recovery 5 Jan 2010 01:10 GMT
... product failed to dampen the optimistic mood, with economists writing off the setback as pharmaceutical industry volatility. Purchasing managers' index reports for China, South Korea, Taiwan and India appeared to confirm that a robust and widespread recovery continues ...
- Manufacturing Expands; World Stocks, Oil Rise 4 Jan 2010 23:51 GMT
... U.S., China and India showed expansion. Emerging markets rallied with resource linked economies leading. The ... Inc for additional $39.3 billion. The Swiss pharmaceutical giant will pay $28.1 billion to gain ... 0.23% to 1,275.75. The Kospi Index in South Korea increased 13.37 or 0.79% to close ...
- Asian economic rebound 4 Jan 2010 20:51 GMT
... in the city-state as a consequence of pharmaceutical industry volatility. Purchasing managers’ index reports for China, ... volatility. Purchasing managers’ index reports for China, South Korea, Taiwan and India appeared to confirm ...
- Asia's recovery star burns brightest 4 Jan 2010 20:31 GMT
... alongside steady improvements in the data from South Korea and Taiwan. In China and India, ... in the city-state as a consequence of pharmaceutical industry volatility. The Singapore ministry of trade and ...
- Corporate Tax Returns Face Heightened Scrutiny 4 Jan 2010 19:31 GMT
... how much profit is made by a company in each country in which it operates, ... KPMG study found that China, India, Australia, South Korea and Japan in particular have intensified ... financial services companies, natural resource groups and pharmaceutical giants. But few companies will discuss the ...
- ADENTRX set to move in on GlaxoSmithKline's lucrative oncology drug (NYS,ASE:GSK,ANX) 4 Jan 2010 19:11 GMT
... the trail of creating improved equivalent ethical pharmaceutical products. Many of them quickly became multi-billion ... is planned. ADVENTRX has already partnered for South Korea and ANX-514 could also have the ... Barney. He now works in the pharmaceutical industry and is a contributor to BioMedReports. Disclosure: ...
- CrystalGenomics Appoints New Vice President of Business Development 4 Jan 2010 18:30 GMT
... Appoints New Vice President of Business Development SEOUL, South Korea, Jan. 4 /PRNewswire/ -- CrystalGenomics, Inc. (Seoul, Korea) ... -- CrystalGenomics, Inc. (Seoul, Korea) and CG Pharmaceuticals, Inc. (Emeryville, California) a leading biopharmaceutical company ...
- Cash-Strapped Governments Step Up Scrutiny of Corporate Tax Returns 4 Jan 2010 18:30 GMT
... how much profit is made by a company in each country in which it operates, ... KPMG study found that China, India, Australia, South Korea and Japan in particular have intensified ... financial services companies, natural resource groups and pharmaceutical giants. But few companies will discuss the ...
Powered by 
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>> | |
Country Info About South Korea
| |
|
04 January 2010
29 December 2009
28 December 2009
|
a digital news provider
cnn.com:
yahoo.com:
telegraph.co.uk:
latimes.com:
guardian.co.uk: